236
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical and Computed Tomography Features Associated with Multidrug-Resistant Pulmonary Tuberculosis: A Retrospective Study in China

, ORCID Icon, , , , ORCID Icon & show all
Pages 651-659 | Received 19 Oct 2022, Accepted 06 Jan 2023, Published online: 30 Jan 2023

References

  • World Health Organization (WHO), Global tuberculosis report 2022. Geneva, Switzerland; 2022. Available from: https://www.who.int/publications/i/item/9789240061729. Accessed January 9, 2023.
  • Karki M, Kantipudi K, Yang F, et al. Generalization challenges in drug-resistant tuberculosis detection from chest X-rays. Diagnostics. 2022;12:1889. doi:10.3390/diagnostics12010188
  • Li D, He W, Chen B, Lv P. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV infected patients: comparisons of CT findings. PLoS One. 2017;12:e0176354. doi:10.1371/journal.pone.0176354
  • Song Q, Guo X, Zhang L, Yang L, Lu X. New approaches in the classification and prognosis of sign clusters on pulmonary CT images in patients with multidrug-resistant tuberculosis. Front Microbiol. 2021;12:714617. doi:10.3389/fmicb.2021.714617
  • Fox L, Kramer MR, Haim I, Priess R, Metvachuk A, Shitrit D. Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis. 2011;30:863–867. doi:10.1007/s10096-011-1167-4
  • Parvaneh B, Payam T, Ehsan C, et al. Risk factors associated with multidrug-resistant tuberculosis. Tanaffos. 2009;8:17–21.
  • Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014;18:1195–1201. doi:10.5588/ijtld.14.0192
  • Du L, Zhang Y, Lv X, et al. Prevalence of multidrug-resistant tuberculosis in dalian, china: a retrospective study. Infect Drug Resist. 2021;14:1037–1047. doi:10.2147/IDR.S294611
  • Feng M, Xu Y, Zhang X, et al. Risk factors of multidrug-resistant tuberculosis in China: a meta-analysis. Public Health Nurs. 2019;36:257–269. doi:10.1111/phn.12582
  • Yang F, Yu H, Kantipudi K, et al. Differentiating between drug-sensitive and drug-resistant tuberculosis with machine learning for clinical and radiological features. Quant Imaging Med Surg. 2022;12:675–687. doi:10.21037/qims-21-290
  • Khawbung JL, Nath D, Chakraborty S. Drug resistant Tuberculosis: a review. Comp Immunol Microbiol Infect Dis. 2021;74:101574. doi:10.1016/j.cimid.2020.101574
  • Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8:19. doi:10.1016/S2213-2600(19)30418-7
  • Agustin H, Massi MN, Djaharuddin I, et al. Analysis of CD4 and CD8 expression in multidrug-resistant tuberculosis infection with diabetes mellitus: an experimental study in mice. Ann Med Surg. 2021;68:102596. doi:10.1016/j.amsu.2021.102596
  • Prezzemolo T, Guggino G, La Manna MP, et al. Functional signatures of human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Front Immunol. 2014;5:180. doi:10.3389/fimmu.2014.00180
  • Yildiz P, Kadakal F, Tütüncü Y, et al. Natural killer cell activity in multidrug-resistant pulmonary tuberculosis. Respiration. 2001;68:590–594. doi:10.1159/000050577
  • Li N, Xie WP, Kong H, et al. Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015;19:1230–1238. doi:10.5588/ijtld.15.0148
  • Geffner L, Yokobori N, Basile J, et al. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun. 2009;77:5025–5034. doi:10.1128/IAI.00224-09
  • Sun ET, Xia D, Li BH, et al. Association of immune factors with drug-resistant tuberculosis: a case-control study. Med Sci Monit. 2017;23:5330–5336. doi:10.12659/msm.904309
  • Song T, Li LJ, Liu JL, Geng SJ. Study on the relationship between changes of immune cells and TNF-α in peripheral blood of patients with multidrug-resistant and extensively drug-resistant tuberculosis. Eur Rev Med Pharmacol Sci. 2018;22:1061–1065. doi:10.26355/eurrev_201802_14389
  • Zahran WA, Ghonaim MM, Koura BA, El-Banna H, Ali SM, El-Sheikh N. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis. Egypt J Immunol. 2006;13:67–78.
  • Bose M, Gupta A, Banavalikar JN, Saha K. Dysregulation of homeostasis of blood T-lymphocyte subpopulations persists in chronic multibacillary pulmonary tuberculosis patients refractory to treatment. Tuber Lung Dis. 1995;76:59–64. doi:10.1016/0962-8479(95)90581-2
  • Yeom JA, Jeong YJ, Jeon D, et al. Imaging findings of primary multidrug-resistant tuberculosis: a comparison with findings of drug-sensitive tuberculosis. J Comput Assist Tomogr. 2009;33:956–960. doi:10.1097/RCT.0b013e31819877ab
  • Wáng YXJ, Chung MJ, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M. Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences. Quant Imaging Med Surg. 2018;8:161–173. doi:10.21037/qims.2018.03.06
  • Mehrian P, Farnia P, Jalalvand D, et al. Computerised tomography scan in multi-drug-resistant versus extensively drug-resistant tuberculosis. Pol J Radiol. 2020;85:e39–e44. doi:10.5114/pjr.2020.93123
  • Shin HS, Choi DS, Na JB, et al. Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: a comparison with primary drug sensitive tuberculosis. PLoS One. 2020;15:e0239431. doi:10.1371/journal.pone.0239431
  • Koo HK, Min J, Kim HW, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20:622. doi:10.1186/s12879-020-05350-7
  • Hms EA, Urbanowski ME, Bishai WR, Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation, Am J Pathol. 188(2018)1666–1675.
  • Sakhelashvili M, Kostyk O, Sakhelashvili-Bil O, Piskur Z. Features of the resistant forms of a specific process among children and teenagers from the multidrug-resistant tuberculous infection foci: clinical picture and diagnostics. Georgian Med News. 2021;2021:70–76.
  • Zeng Y, Zhai XL, Wáng YX, et al. Illustration of a number of atypical computed tomography manifestations of active pulmonary tuberculosis. Quant Imaging Med Surg. 1651-1667;11(2021). doi:10.21037/qims-20-1323
  • Lee JY, Lee KS, Jung KJ, et al. Pulmonary tuberculosis: CT and pathologic correlation. J Comput Assist Tomogr. 2000;24:691–698. doi:10.1097/00004728-200009000-00005
  • Im JG, Itoh H, Lee KS, Han MC. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging. 1995;36:227–285.
  • Cheng N, Wu S, Luo X, et al. A comparative study of chest computed tomography findings: 1030 cases of drug-sensitive tuberculosis versus 516 cases of drug-resistant tuberculosis. Infect Drug Resist. 2021;14:1115–1128. doi:10.2147/IDR.S300754
  • Jeong YJ, Lee KS. Pulmonary tuberculosis: up-to-date imaging and management. AJR Am J Roentgenol. 2008;191:834–844. doi:10.2214/AJR.07.3896
  • Cha J, Lee HY, Lee KS, et al. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol. 2009;10:207–216. doi:10.3348/kjr.2009.10.3.207